Skip to main content

Advertisement

Table 2 Efficacy

From: Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lung cancer

  arm A arm B  
  (n = 25) (n = 24) p-value
CR 0 0  
PR 9 4  
SD 7 8  
PD 8 5  
NE 1 7  
RR(%) 36.0 16.7 0.13
DCR(%) 64.0 50.0 0.32